Asian Spectator

Men's Weekly

.

Menarini Group's Elacestrant Marketing Authorization Applicati...

  • Written by LATEST ASIANET NEWS RELEASES
  • Published in Asia Net
FLORENCE, Italy and NEW YORK, Aug. 19, 2022 / PRNewswire-AsiaNet/ -- - Elacestrant, if approved, would be the first oral selective estrogen receptor degrader (SERD) to be available for patients suffering from second-line (2L) and third-line (3L) ER+/HER2- advanced or metastatic breast cancer in the European Union...

Authors: LATEST ASIANET NEWS RELEASES

Read more

Magazine

Cracking the code: How a “prediction machine” is resurrecting the Singapore Stone

Singapore Stonewikipedia.org, CC BYSeveral years ago, my linguistic research team and I began developing a computational tool we call ‘Read-y Grammarian’. Our goal was to reconstruct the h...

Transisi energi berkeadilan: benar nyata atau hanya jargon semata?

TomFisk?Pexels, CC BYDunia memang sedang bergerak menuju energi yang lebih hijau demi kelestarian Bumi. Namun di lain sisi, ada jutaan pekerja yang menggantungkan hidup dari industri ekstraktif, seper...

Gaya maskulin pemerintah memulihkan bencana Sumatra: Hanya mau mengatur, tapi enggan menafkahi dan melindungi

Presiden Prabowo Subianto saat meninjau posko pengungsi di MAN 1 Langkat, Kabupaten Langkat, Sumatra Utara, pada 13 Desember 2025.Kris/Biro Pers Sekretariat Presiden● Dalam penanganan bencana, n...